Austin Private Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,070
Closed -$317K 267
2024
Q1
$317K Buy
6,070
+1,427
+31% +$72.7K 0.04% 167
2023
Q4
$238K Buy
4,643
+994
+27% +$52.2K 0.03% 178
2023
Q3
$212K Sell
3,649
-179
-5% -$11K 0.03% 158
2023
Q2
$245K Sell
3,828
-100
-3% -$6.71K 0.04% 141
2023
Q1
$272K Buy
+3,928
New +$277K 0.04% 126
2022
Q3
Sell
-3,225
Closed -$248K 137
2022
Q2
$248K Buy
+3,225
New +$246K 0.05% 111
2021
Q1
Sell
-12,671
Closed -$786K 115
2020
Q4
$786K Buy
+12,671
New +$779K 0.23% 39

Other funds holding BMY

Austin Private Wealth's BMY Position: Q2 2024 in Review

Austin Private Wealth sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 6,070 shares — an estimated $317K sold.

Austin Private Wealth first reported a position in BMY in Q4 2020 and held it in 7 quarters. The position peaked at $786K in Q4 2020. 2,152 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

  • Austin Private Wealth reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
  • Austin Private Wealth sold 6,070 Bristol-Myers Squibb shares in Q2 2024, an estimated $317K.
  • Austin Private Wealth first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 7 quarters.
  • Austin Private Wealth's Bristol-Myers Squibb position peaked at $786K in Q4 2020.
  • 2,152 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Austin Private Wealth's 13F filing for Q2 2024, filed 12 Jul 2024.